135 related articles for article (PubMed ID: 28328834)
1. Varying postresection lactate dehydrogenase with overall survival of early stage pancreatic cancer patients: A retrospective study.
Xiao Y; Xie Z; Shao Z; Chen W; Xie H; Qin G; Zhao N
Medicine (Baltimore); 2017 Mar; 96(12):e6399. PubMed ID: 28328834
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach.
Xiao Y; Xie H; Xie Z; Shao Z; Chen W; Qin G; Zhao N
Cancer Med; 2016 May; 5(5):881-7. PubMed ID: 26864727
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients: A meta-analysis of 18 observational studies.
Gan J; Wang W; Yang Z; Pan J; Zheng L; Yin L
Medicine (Baltimore); 2018 Nov; 97(46):e13151. PubMed ID: 30431587
[TBL] [Abstract][Full Text] [Related]
6. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
[TBL] [Abstract][Full Text] [Related]
7. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.
Faloppi L; Bianconi M; Giampieri R; Sobrero A; Labianca R; Ferrari D; Barni S; Aitini E; Zaniboni A; Boni C; Caprioni F; Mosconi S; Fanello S; Berardi R; Bittoni A; Andrikou K; Cinquini M; Torri V; Scartozzi M; Cascinu S;
Oncotarget; 2015 Oct; 6(33):35087-94. PubMed ID: 26397228
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Preoperative Serum Lactate Dehydrogenase in Upper Urinary Tract Urothelial Carcinoma.
Zhang XK; Zhang ZL; Lu X; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Clin Genitourin Cancer; 2016 Aug; 14(4):341-345.e3. PubMed ID: 26868330
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase as promising marker for prognosis of brain metastasis.
Pei YY; Zhang Y; Liu ZR; He Y; Yu JY; Zhang RJ; Wang JJ; Peng XC; Fang F
J Neurooncol; 2022 Sep; 159(2):359-368. PubMed ID: 35794505
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Role of Lactate Dehydrogenase Expression in Urologic Cancers: A Systematic Review and Meta-Analysis.
Zhang Y; Xu T; Wang Y; Zhang H; Zhao Y; Yang X; Cao Y; Yang W; Niu H
Oncol Res Treat; 2016; 39(10):592-604. PubMed ID: 27710971
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.
Zhang J; Yao YH; Li BG; Yang Q; Zhang PY; Wang HT
Sci Rep; 2015 Apr; 5():9800. PubMed ID: 25902419
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.
Tas F; Aykan F; Alici S; Kaytan E; Aydiner A; Topuz E
Am J Clin Oncol; 2001 Dec; 24(6):547-50. PubMed ID: 11801751
[TBL] [Abstract][Full Text] [Related]
15. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
17. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
[TBL] [Abstract][Full Text] [Related]
18. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.
Cheng SH; Jian JJ; Tsai SY; Chan KY; Yen LK; Chu NM; Tan TD; Tsou MH; Huang AT
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):755-62. PubMed ID: 9652835
[TBL] [Abstract][Full Text] [Related]
19. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
20. Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer.
Xiao Y; Lu J; Chang W; Chen Y; Li X; Li D; Xu C; Yang H
BMC Cancer; 2019 Aug; 19(1):785. PubMed ID: 31391026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
